Products 2023 – Brains Bioceutical

Products

We possess a unique suite of the most difficult to obtain approvals and licenses, guaranteeing pharma-grade products of the highest quality, consistency and standardization

Pharma

Brains is one of the only secure supplies of standardised THC-free, API of natural origin worldwide.

Schedule 1 Domestic License for the handling and R&D of THC
Certificate of EU-GMP and API compliance (human and veterinary)
First to market with a plant-based specials medicine with the MHRA in the UK and Brazil

Regulatory Package

Brains Bio’s market leading position is further enhanced by its regulatory package, which includes:

An actively maintained EU Active Substance Master File (ASMF).
A US Drug Master File (DMF) filed with the US Food and Drug Administration (FDA),
Drug Substance (DS) section of the Investigational Medicinal Product Dossier (IMPD)
German DAC monograph compliant.
Drug Product (DP) section of the IMPD available from a third party partner company
36-Month stability data.
Over 350 commercial batches manufactured with resulting batch consistency and standardisation data.
Approved IND filings with the US FDA. Non-GMO, Kosher, Halal
Tested as being free of THC and banned substances by informed Choice, NSF and INRS (a WADA certified lab)
NSF certified

Nutra

Brains Bio delivers the highest quality, evidence-based, global-scale supply of pharma-grade natural CBD in leading wellness stores. With over 100 product formulation rights from global best-in-class SKUs, Brains manufactures a line of wellness products including oils, sprays, creams, balms, and capsules.

Global Leaders

Exclusive relationship between nutra market leader Vitabiotics and Brains PURE. The partnership’s complementary product positioning ensures the two brands do not compete.

27% of vitamin sales in the UK
Exclusive wellness deal using Brains Bio CBD API
Leading European vitamin company
Distributes in over 100 countries
Co-branding opportunity
Commercial use agreement for ‘Brains Inside’
Tested by leading sports accreditation authorities

Quality Assurance

100% natural hemp derived
Consistent quality
uScience-backed uGMP certified (Human & Veterinary)
3-year stability data (incl. Zone IVb)
UK MHRA registered
US DMF
EU ASMF
Pipeline of cannabinoid APIs available in
2023 (D9-THC, D8-THC, CBN, CBG)

Specification

98% – 102% pure CBD isolate with
impurity profile <0.15%
Zero tetrahydrocannabinol (THC) with
limit of detection 0.000006%, which is
lowest in the market

Product Line

Brains Bio will soon be offering its own line of CBD oils, sprays, creams and capsules under the “Brains Pure CBD” brand.

CBD Oil

Available Options

375mg

500mg

750mg

1000mg

1500mg

3000mg

CBD Oil + Vitamins

Available Options

500mg
Vitamin D+

1000mg
Vitamin D+

CBD Spray

Available Options

50mg
Berry

50mg
Melon

50mg
Grape

CBD Skin Cream

Available Options

750mg
Skin Cream

CBD Balm

Available Options

900mg
Balm

CBD Capsules

Available Options

10mg

20mg

CBD Capsules + Vitamins

Available Options

20mg
Turmeric

20mg
Curcumin

20mg
Ashwaganda

20mg
Turmeric

20mg
5HTP

20mg
Sib Ginseng

20mg
Magnesium

Jas Kalsi

An experienced Chartered Professional Accountant with over 30 years of experience in providing personal and corporate taxation, corporate restructuring, financing, public offering and human resources management services. Kalsi is the Chief Financial Officer for Brains Bioceutical Corp., a global manufacturer of naturally-sourced active pharmaceutical ingredients (APIs). In this role, Kalsi is responsible for overseeing and managing the fiscal health of the group, implementing best practices with respect to finance, accounting and internal controls, obtaining funding, providing recommendations on mergers and acquisitions and working collaboratively with the CEO and Board of Directors on strategy. In addition, Kalsi will be responsible to regulatory entities and authorities, including any security exchange commissions.

Kalsi was an audit partner at KPMG focusing on small, medium and large private, government sector and public audit clients. He was the Human Resource Manager in charge of recruiting, staff development and training, and a member of KPMG’s Professional Practice Group. Subsequent to KPMG, Kalsi was the Chief Financial Officer / Chief Executive Officer of a variety of private companies including 6.5 years with a pharmaceutical fulfillment provider and API developer.

Kalsi has a proven track record in hiring top-level senior executives, restructuring companies to minimize tax and maximize cash flows, raising financing and creating a cohesive culture.

Kalsi has a passion for wellness and has created several initiatives and partnered with several leading-edge individuals to help people create and enjoy the best versions of themselves. He sees the use cannabinoids as a major tool to facilitate one’s optimum lifestyle.

With the team and infrastructure in place, Brains Bioceutical has quickly become an industry leader in both the nutraceutical and pharmaceutical cannabinoid industries, with several clinical trials and academic studies underway evaluating the efficacy of cannabinoids to treat major diseases. Under Kalsi’s leadership, Brains Bioceutical has already established market dominance, as it is the only company in the world to sell bulk API commercially around the world, supporting both the pharmaceutical and wellness sectors. With ambitious plans to expand Brains Bioceutical into a global biotech company specializing in cannabinoid health and wellness solutions, Kalsi is pioneering a new frontier in medicinal and wellness solutions across the world.

Products

We possess a unique suite of the most difficult to obtain approvals and licenses, guaranteeing pharma-grade products of the highest quality, consistency and standardization

Pharma

Regulatory Package

Brains Bio’s market leading position is further enhanced by its regulatory package, which includes:

Nutra

Global Leaders